An ex vivo model to study hormone action in the human breast

Journal of Visualized Experiments

Volumn , Issue 95, 2015, Pages

  Sflomos, George ^a  

^a EPFL   (Switzerland)

Author keywords

Breast cancer; Breast tissue microstructures; Estrogen; Ex vivo model; Hormone signaling; Issue 95; Mammary epithelial cells; Medicine; Microenvironment; Paracrine signaling; Progesterone; Reduction mammoplasty; Tissue architecture; Tissue digestion

Indexed keywords

EID: 84921684942     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/52436     Document Type: Article

References (15)

1. Beral, V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 362, (9382), 419-427 (2003).
2. MacMahon, B., et al. Age at first birth and breast cancer risk. Bull World Health Organ. 43, (2), 209-221 (1970).
3. Pike, M. C., Krailo, M. D., Henderson, B. E., Casagrande, J. T., Hoel, D. G. 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature. 303, (5920), 767-770 (1983).
4. Brisken, C., O’Malley, B. Hormone action in the mammary gland. Cold Spring Harb Perspect Biol. 2, (12), a003178(2011).
5. Levenson, A. S., Jordan, V. C. MCF-7: the first hormone-responsive breast cancer cell line. Cancer Res.57, (15), 3071-3078 (1997).
6. Tanos, T., Rojo, L. J., Echeverria, P., Brisken, C. ER and PR signaling nodes during mammary gland development. Breast Cancer Res. 14, (4), 210(2012).
7. Roskelley, C., Desprez, P., Bissell, M. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc Natl Acad Sci U S A. 91, (26), 12378-12382 (1994).
8. Kass, L., Erler, J. T., Dembo, M., Weaver, V. M. Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis. Int J Biochem Cell Biol. 39, (11), 1987-1994 (2007).
9. Graham, J. D., et al. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology. 150, (7), 3318-3326 (2009).
10. Wang, J., et al. Comment on #34;Progesterone/RANKL is a major regulatory axis in the human breast". Sci Transl Med. 5, (215), 215le214(2013).
11. Brisken, C. Progesterone signalling in breast cancer: a neglected hormone coming into the limelight. Nat Rev Cancer. 13, (6), 385-396 (2013).
12. Xu, R., Boudreau, A., Bissell, M. J. Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices. Cancer Metastasis Rev. 28, (1-2), 167-176 (2009).
13. Tanos, T., et al. Progesterone/RANKL is a major regulatory axis in the human breast. Sci Transl Med. 5, (182), 182ra155(2013).
14. Yalcin-Ozuysal, O., et al. Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fate.Cell Death Differ. 17, (10), 1600-1610 (2010).
15. Hines, W. C., Su, Y., Kuhn, I., Polyak, K., Bissell, M. J. Sorting out the FACS: a devil in the details. Cell Rep. 6, (5), 779-781 (2014).